Brainstorm Cell Therapeutics (NASDAQ:BCLI) Stock Price Passes Above 200-Day Moving Average – Should You Sell?

Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI - Get Free Report)'s stock price passed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.65 and traded as high as $0.90. Brainstorm Cell Therapeutics shares last traded at $0.87, with a volume of 9,450 shares. Brainstorm Cell Therapeutics Stock